US 9421254
Immunostimulatory combinations of TLR ligands and methods of use
granted A61KA61K2039/55516A61K2039/55561
Quick answer
US patent 9421254 (Immunostimulatory combinations of TLR ligands and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/55516, A61K2039/55561, A61K2039/57, A61K39/21